Based on 10 analysts giving stock ratings to Context Therapeutics Inc in the past month.
In the current month, CNTX has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CNTX average Analyst price target in the last month is 4.375.
Based on analysts' estimates, CNTX EPS is projected to reach -0.106 in FY2026Q4, following reported EPS of -0.080 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.08, while Context Therapeutics IncCNTX's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD -0.11.